World Markets

Ebola vaccine doses to be stockpiled for emergency outbreak use

Credit: REUTERS/Baz Ratner

The global vaccine alliance GAVI said on Thursday it had agreed to fund and create a $178 million stockpile of Ebola vaccines for emergency use in outbreaks.

Adds details of stockpile

LONDON, Dec 5 (Reuters) - The global vaccine alliance GAVI said on Thursday it had agreed to fund and create a $178 million stockpile of Ebola vaccines for emergency use in outbreaks.

The aim is for a global stock of 500,000 doses of vaccine against the deadly haemorrhagic fever, GAVI said in a statement. The stockpiling will start with Merck's MRK.N newly developed Ervebo vaccine, which won regulatory approval last month.

The plan is for poor and middle-income countries to be able to access the stockpile free of charge, GAVI said, while other countries will need to refund the cost of any vaccines used.

GAVI is a public-private partnership backed by the Bill & Melinda Gates Foundation, the World Health Organization, the World Bank, UNICEF and others, which arranges bulk buys to reduce vaccine costs for poor countries.

(Reporting by Kate Kelland; editing by Kevin Liffey)

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Other Topics

US Markets

Latest Markets Videos

Reuters

Reuters, the news and media division of Thomson Reuters, is the world’s largest international multimedia news provider reaching more than one billion people every day. Reuters provides trusted business, financial, national, and international news to professionals via Thomson Reuters desktops, the world's media organizations, and directly to consumers at Reuters.com and via Reuters TV.

Learn More